Mangaluru accords a rousing reception for Navanath Zhundi

Bengaluru, Jun 2: Chief Minister BS Yediyurappa on Tuesday interacted with District Collectors (DCs) and Superintendents of Police (SPs) regarding COVID- 19 situation in the State.

In the meeting held through a video conference, he said that DCs, SPs and the District Panchayat Chief Executive Officer (CEO) be divided into taluks and ordered them to take appropriate measures to control COVID-19.

He was speaking today in a video conversation with District Collector, District Panchayat Chief Executives and Superintendents of Police in Kalaburgi, Vijayapura, Udupi, Yadagiri, Raichuru and Belagavi districts regarding measures to control the spread of COVID-19.

The Chief Minister instructed officials to monitor the investments in taluka centres. He also ordered to create a task force in the village panchayats, who will be monitoring things closely.

The Chief Minister also directed for the creation of ward-level watchdog committee in every village and city and an FIR should be registered in case of a home quarantine violation.

Home Minister Basavaraja Bommai, Revenue Minister R Ashok, Chief Secretary TM Vijayabhaskar, Development Commissioner Vandita Sharma, Police Chief Director Praveen Sood, Health Department general secretary Javed Akhtar and secretary Pankaj Kumar Pandey were also present in the meeting.

Bengaluru, May 14: Three youths died of "asphyxiation" when they fell into a pit in the abandoned Kolar gold field mines, where they had gone to allegedly steal iron material early on Thursday, police said.

On Wednesday night, the trio had entered the gold mine in Kolar district, about 100 km from Bengaluru, and fell in the pit after losing balance.

After inhaling the poisonous gas in the pit, they were asphyxiated to death, they said.

"It was a seven hour exercise after which we could bring out two bodies. Work is on to retrieve the third," a police officer told .

Police reached the spot after they were alerted by the accomplices of the deceased.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.